Actively Recruiting
Omics Sequencing of Specimen Derived From Mother-Infant-Pairs
Led by Zhujiang Hospital · Updated on 2023-07-25
100
Participants Needed
1
Research Sites
288 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators aim to collect breast-milk and feces from the participants, and apply culture techniques as well as omics sequencing technology to probe into the microbial and metabolomic signature of the specimens.
CONDITIONS
Official Title
Omics Sequencing of Specimen Derived From Mother-Infant-Pairs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy pregnant women aged between 20 and 40 years
- Vaginal birth
- Body mass index (BMI) less than 23.5 before pregnancy
- Infant birth weight between 2500g and 4000g
You will not qualify if you...
- Gestational diabetes
- Diagnosis of depressive disorder during pregnancy
- Gestational hypertension
- Diagnosis of other diseases during pregnancy
- Probiotics or antibiotic treatment from 3 months before pregnancy to 3 months after delivery
- History of smoking and alcohol drinking
- History of diarrhea from 3 months before pregnancy to 3 months after delivery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhujiang Hospital
Guangzhou, Guangdong, China
Actively Recruiting
Research Team
Y
Ying Ma, Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here